(Press-News.org) OAK BROOK, Ill. – Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
COPD is a group of progressive lung diseases that impair a person’s ability to breathe. Symptoms typically involve shortness of breath and fatigue. There currently is no cure for COPD, and it is the third leading cause of death worldwide, according to the World Health Organization.
A spirometry test, also known as a pulmonary function test, is traditionally used to diagnose COPD. It measures lung function through the quantity of air that can be inhaled and exhaled as well as the speed of exhalation.
CT images of the lungs can aid in COPD diagnosis. The procedure typically requires two image acquisitions, one at full inhalation, called inspiratory, and one at normal exhalation, called expiratory.
“Although studies have recently shown that lung structure, quantitatively measured using lung CT, can supplement COPD severity staging, diagnosis and prognosis, many of these studies require the acquisition of two CT images,” said study author Kyle A. Hasenstab, Ph.D., assistant professor of Statistics and Data Science at San Diego State University, California. “However, this type of protocol is not clinically standard across institutions.”
Some hospitals are unable to implement expiratory CT protocols due to the added training requirements.
“Implementation of expiratory CT protocols may not be feasible at many institutions due to the need for technologist training to acquire the images and radiologist training to interpret the images,” Dr. Hasenstab said.
Additionally, some elderly patients with impaired lung function struggle with holding their breath, as is required during exhalation image acquisition. This may impact the quality of CT images and the accuracy of diagnosis.
Dr. Hasenstab and colleagues hypothesized that a single inhalation CT acquisition combined with a convolutional neural network (CNN), and clinical data would be sufficient for COPD diagnosis and staging. A CNN is a type of artificial neural network that uses deep learning to analyze and classify images.
In this retrospective study, the inhalation and exhalation lung CT images and spirometry data were acquired from 8,893 patients from November 2007 to April 2011. The average age of the patients included in the study was 59 years and all had a history of smoking.
The CNN was trained to predict spirometry measurements using clinical data and either a single-phase or multi-phase lung CT.
The spirometry predictions were then used to predict the Global Initiative for Obstruct Lung Disease (GOLD) stage. The GOLD system classifies the severity of a patient’s COPD into one of four stages, with one classified as mild COPD and four classified as very severe COPD.
The results of the study showed that a CNN model developed using only a single respiratory phase CT image accurately diagnosed COPD and was also accurate within one GOLD stage.
The model performed similarly to COPD diagnoses that used combined inhalation and exhalation CT measurements.
“Although many imaging protocols for COPD diagnosis and staging require two CT acquisitions, our study shows that COPD diagnosis and staging is feasible with a single CT acquisition and relevant clinical data,” Dr. Hasenstab said.
When clinical data was added, the CNN model’s predictions were even more accurate.
CNN models that used only inhalation or exhalation data respectively performed the same. This suggests that certain markers used for COPD diagnosis may overlap across images.
“Reduction to a single inspiratory CT acquisition can increase accessibility to this diagnostic approach while reducing patient cost, discomfort and exposure to ionizing radiation,” Dr. Hasenstab said.
###
Evaluating the Cumulative Benefit of Inspiratory CT, Expiratory CT, and Clinical Data for COPD Diagnosis and Staging through Deep Learning.” Collaborating with Dr. Hasenstab were Amanda N. Lee, B.S., and Albert Hsiao, M.D., Ph.D.
Radiology: Cardiothoracic Imaging is edited by Suhny Abbara, M.D., University of Texas Southwestern Medical Center, Dallas, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/cardiothoracic)
RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research, and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)
For patient-friendly information on chest CT, visit RadiologyInfo.org.
END
Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE®) to current standard-of-care first-line maintenance therapy (following induction chemotherapy) resulted in statistically significant and clinically meaningful improvement in progression-free survival (PFS) by investigator assessment in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) metastatic ...
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
The results of this study were simultaneously published in JAMA Oncology.
“Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who ...
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the same breast, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“Good-risk” DCIS was defined as grade 1 or 2, 2.5 cm or smaller, and having clear surgical margins of 3 mm or greater.
Current guidelines from the National Comprehensive Cancer Network (NCCN) advise that patients who undergo breast-conserving surgery after a diagnosis ...
SAN ANTONIO – Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast cancer recurrence rates as those who underwent guideline-concordant treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
The results of this study were simultaneously published in JAMA.
“Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who develop cancer.
A steady increase ...
SAN ANTONIO – Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“While post-mastectomy CWI is the standard of care for most patients with early-stage breast cancer who have four or more positive axillary lymph nodes, its role in patients with fewer positive lymph nodes or node-negative disease remains controversial,” ...
About The Study: Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the same breast at 2 years compared with those randomized to guideline-concordant care.
Corresponding Author: To contact the corresponding author, E. Shelley Hwang, MD, MPH, email shelley.hwang@duke.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.26698)
Editor’s Note: Please ...
About The Study: In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) prospective randomized trial, the overall lived experience of women randomized to undergo active monitoring for low-risk ductal carcinoma in situ was similar to that of women randomized to guideline-concordant care during the 2 years following diagnosis.
Corresponding Author: To contact the corresponding author, Ann H. Partridge, MD, MPH, email ann_partridge@dfci.harvard.edu.
To access the embargoed study: Visit our For The Media website ...
Not only are they the smallest among us, premature children also face health and life challenges that make them the most vulnerable. Generally speaking, they have a slightly higher risk of mortality due to illness. It is now apparent that they also have a higher risk of unexpected death from so-called external causes: road traffic accidents, substance abuse and suicide.
This has been revealed in a major Nordic study led by Professor Kari Risnes from the Faculty of Medicine and Health Sciences at the Norwegian University of Science and Technology (NTNU). The researchers have analyzed birth data and causes of death for nearly 37,000 individuals aged between 15 ...
Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19. Bovhyaluronidase azoximer, marketed under the brand name Longidaza, is a polymer-conjugated hyaluronidase with an extended half-life. The study drug and placebo were administered for 71 days, with an observation period extending to Day 180.
Longidaza demonstrated a statistically significant 62% reduction in the proportion of patients with exertional desaturation ...
Mosasaurs are extinct marine lizards, spectacular examples of which were first discovered in 1766 near Maastricht in the Netherlands, fueling the rise of the field of vertebrate palaeontology (the study of fossil remains of animals with backbones). Palaeontologist Michael Polcyn presented the most comprehensive study to date on the early evolution and ecology of these extinct marine reptiles. On 16 December, Polcyn will receive his PhD from Utrecht University for his research into the evolution of the mosasaurs. "Mosasaurs are a textbook example of macroevolution, ...